To test whether the Neu allele was also amplified in tumours from the BlgCre-NeuKI model, we tested a subset of tumours with a quantitative PCR (qPCR) approach using a Neu-specific probe on genomic tumour DNA. This evidence concerns the gene ERBB2 and neoplasm.